BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27223083)

  • 1. Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck.
    Flowers SA; Zhou X; Wu J; Wang Y; Makambi K; Kallakury BV; Singer MS; Rosen SD; Davidson B; Goldman R
    Oncotarget; 2016 Jul; 7(28):43177-43187. PubMed ID: 27223083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Extracellular Sulfatase
    Yang Y; Ahn J; Raghunathan R; Kallakury BV; Davidson B; Kennedy ZB; Zaia J; Goldman R
    Front Oncol; 2020; 10():582827. PubMed ID: 33585200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SULFs in human neoplasia: implication as progression and prognosis factors.
    Bret C; Moreaux J; Schved JF; Hose D; Klein B
    J Transl Med; 2011 May; 9():72. PubMed ID: 21599997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
    Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
    Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
    Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
    Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population.
    Salazar-Ruales C; Arguello JV; López-Cortés A; Cabrera-Andrade A; García-Cárdenas JM; Guevara-Ramírez P; Peralta P; Leone PE; Paz-Y-Miño C
    Biomed Res Int; 2018; 2018():9792730. PubMed ID: 30584540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations.
    McLemore MS; Haigentz M; Smith RV; Nuovo GJ; Alos L; Cardesa A; Brandwein-Gensler M
    Head Neck Pathol; 2010 Jun; 4(2):97-105. PubMed ID: 20333562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
    Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
    Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.
    Clauditz TS; Böttcher A; Hanken H; Borgmann K; Sauter G; Wilczak W; Grob T; Münscher A
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):53-61. PubMed ID: 29022097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis.
    Singer MS; Phillips JJ; Lemjabbar-Alaoui H; Wang YQ; Wu J; Goldman R; Rosen SD
    Clin Chim Acta; 2015 Feb; 440():72-8. PubMed ID: 25444749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
    Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.
    Wang Y; Springer S; Mulvey CL; Silliman N; Schaefer J; Sausen M; James N; Rettig EM; Guo T; Pickering CR; Bishop JA; Chung CH; Califano JA; Eisele DW; Fakhry C; Gourin CG; Ha PK; Kang H; Kiess A; Koch WM; Myers JN; Quon H; Richmon JD; Sidransky D; Tufano RP; Westra WH; Bettegowda C; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Agrawal N
    Sci Transl Med; 2015 Jun; 7(293):293ra104. PubMed ID: 26109104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
    Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
    Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.